Believe in Progress
In this episode of the Believe in Progress podcast, the AACR talks with Michael Hugo, who shares his inspiring story of resilience, innovation, and determination in the face of glioblastoma.
Listen and Subscribe
In this episode of the Believe in Progress podcast, the AACR talks with Michael Hugo, who shares his inspiring story of resilience, innovation, and determination in the face of glioblastoma.
Listen and Subscribe
Cancer is not a single disease, but rather a collection of diseases all characterized by the uncontrolled proliferation of cells.
Learn MoreStopping Cancer in its Tracks: Can prevention and early detection significantly reduce the burden of cancer?
Learn MoreNearly 27,000 people in the United States will be diagnosed with stomach, or gastric, cancer this year. Learn about the prevention, screening, and treatment options during Gastric Cancer Awareness Month.
Learn MoreScreening for Early Detection: Using evidence-based guidelines to screen for cancer can help find aberrations at the earliest possible detectable phase of cancer development and progression.
Read the ReportThe current issue of Leading Discoveries magazine features articles on AACR President Patricia M. LoRusso’s efforts to improve clinical trials, an AACR initiative on communicating science effectively, and more.
Read Leading DiscoveriesWhether honoring a special person or a special day, a donation to the American Association for Cancer Research has a lasting impact.
Donate NowSubmit an abstract for the AACR Annual Meeting 2025 (April 25-30, Chicago).
Deadline: November 26
The AACR Cancer Progress Report 2024 highlights research-driven advances against the collection of often devastating diseases we call cancer.
Learn MoreThe AACR and its more than 58,000 members worldwide are advancing a scientifically bold agenda against the collection of diseases we call cancer.
Learn MoreDr. LoRusso, AACR President 2024-2025, explains that basic cancer research is essential to accelerating advances in cancer science and medicine.
Learn Morepercent decrease of the overall age-adjusted cancer death rate in the U.S. from 1991 to 2021
Learn Moretherapeutics were approved for new or expanded uses by the FDA from July 1, 2023, to June 30, 2024
Learn Moremillion cancer survivors in the U.S. are living with, through, and beyond their disease thanks to research
Learn MoreYour donation to the American Association for Cancer Research helps our more than 58,000 members worldwide drive progress against cancer.
Donate Now
